Investment Strategy - Health

health

Our Health is our true Wealth

Maroon seeks to close material innovation and funding gaps in chronic Population Health conditions with a priority on autoimmune diseases (incl. diabetes); blood and cardiovascular health (incl. heart disease); certain cancers (prostate, cervical, ovarian); inflammation; food and environmental allergies; as well as, neurological, mental and brain health.
Our health is our true wealth
Public health investment

9%

Preventative, personalised and public health currently receives only 9% in health investment ~ and has been declining!
public health investment
Brain and mental health

6%

Brain and mental health costs the US Economy $1.5 Tn or 8.8% of GDP p.a., yet receives only 6% of health investment in US, and only 3% globally!
mental health
women health care r&d
LEADING CHRONIC HEALTH CONDITIONS - UNDERFUNDED!

#1

Heart disease is #1 cause of death, $250 Bn cost to the US economy

20% of heart attacks are silent!

Diabetes is 25% of total healthcare costs or $412 Bn
women's health
womens' health

$1 Trn

Womens Health is a $1 Tn economic “opportunity” p.a. by 2040, yet receives only 4% of healthcare R&D, despite women being 50% of economic workforce. Womens Health is NOT niche area, and
represents ALL health matters for women, moving beyond sexual and reproductive health

These chronic Population Health conditions also disproportionately impact women and economically under-represented demographics at scale